[1] Bernal W, Auzinger G, Dhawan A, et al. Acute liver failure. Lancet,2010,376:190-201. [2] Wlodzimirow KA, Eslami S, Abu-Hanna A, et al. Acute liver failure: what is it? Hepatology,2012,55:1306-1307. [3] Wu Z, Han M, Chen T, et al. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int,2010,30:782-794. [4] Brines M, Patel NS, Villa P, et al. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A,2008,105:10925-10930. [5] Wu Y, Zhang J, Liu F, et al. Protective effects of HBSP on ischemia reperfusion and cyclosporine a induced renal injury. Clin Dev Immunol,2013,2013:758159. [6] Yang C, Zhao T, Lin M, et al. Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model. Exp Biol Med (Maywood),2013,238:111-119. [7] Robertson CS, Cherian L, Shah M, et al. Neuroprotection with an erythropoietin mimetic peptide (pHBSP) in a model of mild traumatic brain injury complicated by hemorrhagic shock. J Neurotrauma,2012,29:1156-1166. [8] Collino M, Benetti E, Rogazzo M, et al. A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice. Br J Pharmacol,2014,171:5802-5815. [9] Ueba H, Shiomi M, Brines M, et al. Suppression of coronary atherosclerosis by helix B surface Peptide, a nonerythropoietic, tissue-protective compound derived from erythropoietin. Mol Med,2013,19:195-202. [10] Yuan R, Maeda Y, Li W, et al. Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE. PLoS One,2008,3:e1924. [11] Sarra M, Cupi ML, Bernardini R, et al. IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism. Hepatology,2013,58:1436-1450. [12] Torisu T, Nakaya M, Watanabe S, et al. Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis. Hepatology,2008,47:1644-1654. |